{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:42:07Z","timestamp":1722919327507},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00347-020-01122-5","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T06:02:26Z","timestamp":1590645746000},"page":"579-590","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pseudophakes zystoides Makula\u00f6dem"],"prefix":"10.1007","volume":"117","author":[{"given":"Viola","family":"Radeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"M\u00e4rker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Prahs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\ufeffthar","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"5","key":"1122_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0002-9394(53)90302-x","volume":"36","author":"SR Irvine","year":"1953","unstructured":"Irvine\u00a0SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36(5):599\u2013619. https:\/\/doi.org\/10.1016\/0002-9394(53)90302-x","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1122_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","volume":"76","author":"JD Gass","year":"1966","unstructured":"Gass\u00a0JD, Norton\u00a0EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76(5):646\u2013661. https:\/\/doi.org\/10.1001\/archopht.1966.03850010648005","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1122_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1055\/s-2008-1054397","volume":"187","author":"K Hruby","year":"1985","unstructured":"Hruby\u00a0K (1985) Die Erstbeschreibung des \u201eIrvine-Syndroms\u201c. Klin Monbl Augenheilkd 187(6):549\u2013550. https:\/\/doi.org\/10.1055\/s-2008-1054397","journal-title":"Klin Monbl Augenheilkd"},{"key":"1122_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000411115","volume":"11","author":"GO Naumann","year":"1985","unstructured":"Naumann\u00a0GO, Seibel\u00a0W (1985) Surgical revision of vitreous and iris-incarceration in persisting cystoid maculopathy (Hruby-Irvine-Gass-syndrome)\u2014report on 27 eyes. Dev Ophthalmol 11:181\u2013187. https:\/\/doi.org\/10.1159\/000411115","journal-title":"Dev Ophthalmol"},{"issue":"8","key":"1122_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1055\/s-0031-1299362","volume":"229","author":"T Bertelmann","year":"2012","unstructured":"Bertelmann\u00a0T, Witteborn\u00a0M, Mennel\u00a0S (2012) Das pseudophakiebedingte zystoide Makula\u00f6dem. Klin Monbl Augenheilkd 229(8):798\u2013811. https:\/\/doi.org\/10.1055\/s-0031-1299362","journal-title":"Klin Monbl Augenheilkd"},{"key":"1122_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/CIA.S111761","volume":"11","author":"A Grzybowski","year":"2016","unstructured":"Grzybowski\u00a0A, Sikorski\u00a0BL, Ascaso\u00a0FJ, Huerva\u00a0V (2016) Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging 11:1221\u20131229. https:\/\/doi.org\/10.2147\/CIA.S111761","journal-title":"Clin Interv Aging"},{"issue":"3","key":"1122_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ceo.13513","volume":"47","author":"JV Han","year":"2019","unstructured":"Han\u00a0JV, Patel\u00a0DV, Squirrell\u00a0D, McGhee\u00a0CN (2019) Cystoid macular oedema following cataract surgery: a review. Clin Experiment Ophthalmol 47(3):346\u2013356. https:\/\/doi.org\/10.1111\/ceo.13513","journal-title":"Clin Experiment Ophthalmol"},{"issue":"1","key":"1122_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/ICU.0b013e32834cd5f8","volume":"23","author":"Y Yonekawa","year":"2012","unstructured":"Yonekawa\u00a0Y, Kim\u00a0IK (2012) Pseudophakic cystoid macular edema. Curr Opin Ophthalmol 23(1):26\u201332. https:\/\/doi.org\/10.1097\/ICU.0b013e32834cd5f8","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"1122_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00417-006-0377-4","volume":"245","author":"RF Degenring","year":"2007","unstructured":"Degenring\u00a0RF, Vey\u00a0S, Kamppeter\u00a0B, Budde\u00a0WM, Jonas\u00a0JB, Sauder\u00a0G (2007) Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects. Graefes Arch Clin Exp Ophthalmol 245(1):18\u201323. https:\/\/doi.org\/10.1007\/s00417-006-0377-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1122_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000331277","volume":"227","author":"C Lobo","year":"2012","unstructured":"Lobo\u00a0C (2012) Pseudophakic cystoid macular edema. Ophthalmologica 227(2):61\u201367. https:\/\/doi.org\/10.1159\/000331277","journal-title":"Ophthalmologica"},{"issue":"4","key":"1122_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/02713683.2011.635402","volume":"37","author":"T Kusbeci","year":"2012","unstructured":"Kusbeci\u00a0T, Eryigit\u00a0L, Yavas\u00a0G, Inan\u00a0UU (2012) Evaluation of cystoid macular edema using optical coherence tomography and fundus fluorescein angiography after uncomplicated phacoemulsification surgery. Curr Eye Res 37(4):327\u2013333. https:\/\/doi.org\/10.3109\/02713683.2011.635402","journal-title":"Curr Eye Res"},{"key":"1122_CR12","first-page":"1130","volume":"13","author":"KL Tu","year":"2007","unstructured":"Tu\u00a0KL, Kaye\u00a0SB, Sidaras\u00a0G, Taylor\u00a0W, Shenkin\u00a0A (2007) Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 13:1130\u20131137","journal-title":"Mol Vis"},{"issue":"10","key":"1122_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00347-010-2236-2","volume":"107","author":"WA Herrmann","year":"2010","unstructured":"Herrmann\u00a0WA, Heimann\u00a0H, Helbig\u00a0H (2010) Kataraktoperation. Effekt auf den hinteren Augenabschnitt. Ophthalmologe 107(10):975\u2013984. https:\/\/doi.org\/10.1007\/s00347-010-2236-2 (quiz 985\u2013986)","journal-title":"Ophthalmologe"},{"issue":"2","key":"1122_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","volume":"123","author":"CJ Chu","year":"2016","unstructured":"Chu\u00a0CJ, Johnston\u00a0RL, Buscombe\u00a0C, Sallam\u00a0AB, Mohamed\u00a0Q, Yang\u00a0YC (2016) Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology 123(2):316\u2013323. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.001","journal-title":"Ophthalmology"},{"issue":"2","key":"1122_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ophtha.2016.10.024","volume":"124","author":"O Kristianslund","year":"2017","unstructured":"Kristianslund\u00a0O, R\u00e5en\u00a0M, \u00d8stern\u00a0AE, Drolsum\u00a0L (2017) Late in-the-bag intraocular lens dislocation: a randomized clinical trial comparing lens repositioning and lens exchange. Ophthalmology 124(2):151\u2013159. https:\/\/doi.org\/10.1016\/j.ophtha.2016.10.024","journal-title":"Ophthalmology"},{"issue":"1","key":"1122_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/ICU.0000000000000328","volume":"28","author":"F Boscia","year":"2017","unstructured":"Boscia\u00a0F, Giancipoli\u00a0E, D\u2019Amico Ricci\u00a0G, Pinna\u00a0A (2017) Management of macular oedema in diabetic patients undergoing cataract surgery. Curr Opin Ophthalmol 28(1):23\u201328. https:\/\/doi.org\/10.1097\/ICU.0000000000000328","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"1122_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/IAE.0000000000001552","volume":"38","author":"P Calvo","year":"2018","unstructured":"Calvo\u00a0P, Ferreras\u00a0A, Al Adel\u00a0F, Dangboon\u00a0W, Brent\u00a0MH (2018) Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery. Retina 38(3):490\u2013496. https:\/\/doi.org\/10.1097\/IAE.0000000000001552","journal-title":"Retina"},{"key":"1122_CR18","doi-asserted-by":"publisher","first-page":"4896036","DOI":"10.1155\/2017\/4896036","volume":"2017","author":"C Furino","year":"2017","unstructured":"Furino\u00a0C, Boscia\u00a0F, Niro\u00a0A, Giancipoli\u00a0E, Grassi\u00a0MO, D\u2019Amico Ricci\u00a0G, Blasetti\u00a0F, Reibaldi\u00a0M, Alessio\u00a0G (2017) Combined phacoemulsification and intravitreal dexamethasone implant (Ozurdex\u00ae) in diabetic patients with coexisting cataract and diabetic macular edema. J\u00a0Ophthalmol 2017:4896036. https:\/\/doi.org\/10.1155\/2017\/4896036","journal-title":"J Ophthalmol"},{"issue":"5","key":"1122_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ajo.2015.07.032","volume":"160","author":"LHP Wielders","year":"2015","unstructured":"Wielders\u00a0LHP, Lambermont\u00a0VA, Schouten\u00a0JSAG, van den Biggelaar\u00a0FJHM, Worthy\u00a0G, Simons\u00a0RWP, Winkens\u00a0B, Nuijts\u00a0RMMA (2015) Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 160(5):968\u2013981.e3. https:\/\/doi.org\/10.1016\/j.ajo.2015.07.032","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1122_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00417-018-3954-4","volume":"256","author":"F Schaub","year":"2018","unstructured":"Schaub\u00a0F, Adler\u00a0W, Enders\u00a0P, Koenig\u00a0MC, Koch\u00a0KR, Cursiefen\u00a0C, Kirchhof\u00a0B, Heindl\u00a0LM (2018) Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 256(5):909\u2013917. https:\/\/doi.org\/10.1007\/s00417-018-3954-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1122_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2020.02.004","author":"G Holl\u00f3","year":"2020","unstructured":"Holl\u00f3\u00a0G, Aung\u00a0T, Cantor\u00a0LB, Aihara\u00a0M (2020) Cystoid macula edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2020.02.004","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1122_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12886-017-0405-7","volume":"17","author":"S McCafferty","year":"2017","unstructured":"McCafferty\u00a0S, Harris\u00a0A, Kew\u00a0C, Kassm\u00a0T, Lane\u00a0L, Levine\u00a0J, Raven\u00a0M (2017) Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3\u202f% versus placebo. BMC Ophthalmol 17(1):16. https:\/\/doi.org\/10.1186\/s12886-017-0405-7","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"1122_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jcrs.2013.09.018","volume":"40","author":"AA Hunter","year":"2014","unstructured":"Hunter\u00a0AA, Modjtahedi\u00a0SP, Long\u00a0K, Zawadzki\u00a0R, Chin\u00a0EK, Caspar\u00a0JJ, Morse\u00a0LS, Telander\u00a0DG (2014) Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J\u00a0Cataract Refract Surg 40(4):626\u2013631. https:\/\/doi.org\/10.1016\/j.jcrs.2013.09.018","journal-title":"J Cataract Refract Surg"},{"key":"1122_CR24","doi-asserted-by":"publisher","first-page":"CD010516","DOI":"10.1002\/14651858.CD010516.pub2","volume":"7","author":"VV Juthani","year":"2017","unstructured":"Juthani\u00a0VV, Clearfield\u00a0E, Chuck\u00a0RS (2017) Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database Syst Rev 7:CD10516. https:\/\/doi.org\/10.1002\/14651858.CD010516.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1122_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jcrs.2012.04.034","volume":"38","author":"DRP Almeida","year":"2012","unstructured":"Almeida\u00a0DRP, Khan\u00a0Z, Xing\u00a0L, Bakar\u00a0SN, Rahim\u00a0K, Urton\u00a0T, El-Defrawy\u00a0SR (2012) Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. J\u00a0Cataract Refract Surg 38(9):1537\u20131543. https:\/\/doi.org\/10.1016\/j.jcrs.2012.04.034","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"1122_CR26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jcrs.2006.04.009","volume":"32","author":"ED Donnenfeld","year":"2006","unstructured":"Donnenfeld\u00a0ED, Perry\u00a0HD, Wittpenn\u00a0JR, Solomon\u00a0R, Nattis\u00a0A, Chou\u00a0T (2006) Preoperative ketorolac tromethamine 0.4\u202f% in phacoemulsification outcomes: pharmacokinetic-response curve. J\u00a0Cataract Refract Surg 32(9):1474\u20131482. https:\/\/doi.org\/10.1016\/j.jcrs.2006.04.009","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"1122_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/s0161-6420(00)00538-8","volume":"108","author":"AC Guidera","year":"2001","unstructured":"Guidera\u00a0AC, Luchs\u00a0JI, Udell\u00a0IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108(5):936\u2013944. https:\/\/doi.org\/10.1016\/s0161-6420(00)00538-8","journal-title":"Ophthalmology"},{"issue":"2","key":"1122_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.survophthal.2014.08.005","volume":"60","author":"S Guo","year":"2015","unstructured":"Guo\u00a0S, Patel\u00a0S, Baumrind\u00a0B, Johnson\u00a0K, Levinsohn\u00a0D, Marcus\u00a0E, Tannen\u00a0B, Roy\u00a0M, Bhagat\u00a0N, Zarbin\u00a0M (2015) Management of pseudophakic cystoid macular edema. Surv Ophthalmol 60(2):123\u2013137. https:\/\/doi.org\/10.1016\/j.survophthal.2014.08.005","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1122_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/02713683.2016.1214968","volume":"42","author":"G Mylonas","year":"2017","unstructured":"Mylonas\u00a0G, Georgopoulos\u00a0M, Malamos\u00a0P, Georgalas\u00a0I, Koutsandrea\u00a0C, Brouzas\u00a0D, Sacu\u00a0S, Perisanidis\u00a0C, Schmidt-Erfurth\u00a0U (2017) Comparison of dexamethasone intravitreal implant with conventional triamcinolone in patients with postoperative cystoid macular edema. Curr Eye Res 42(4):648\u2013652. https:\/\/doi.org\/10.1080\/02713683.2016.1214968","journal-title":"Curr Eye Res"},{"issue":"3","key":"1122_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/bjophthalmol-2016-308544","volume":"101","author":"D Bellocq","year":"2017","unstructured":"Bellocq\u00a0D, Pierre-Kahn\u00a0V, Matonti\u00a0F, Burillon\u00a0C, Voirin\u00a0N, Dot\u00a0C, Akesbi\u00a0J, Milazzo\u00a0S, Baillif\u00a0S, Soler\u00a0V, Wolff\u00a0B, Scemama\u00a0C, Malcl\u00e8s\u00a0A, Weber\u00a0M, Kodjikian\u00a0L (2017) Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC\u20112 study. Br J Ophthalmol 101(3):333\u2013341. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308544","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1122_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/IAE.0000000000002044","volume":"39","author":"KL Pepple","year":"2019","unstructured":"Pepple\u00a0KL, Nguyen\u00a0MH, Pakzad-Vaezi\u00a0K, Williamson\u00a0K, Odell\u00a0N, Lee\u00a0C, Leveque\u00a0TK, van Gelder\u00a0RN (2019) Response of inflammatory cystoid macular edema to treatment using oral acetazolamide. Retina 39(5):948\u2013955. https:\/\/doi.org\/10.1097\/IAE.0000000000002044","journal-title":"Retina"},{"key":"1122_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/IMCRJ.S92794","volume":"8","author":"MG Asahi","year":"2015","unstructured":"Asahi\u00a0MG, Bobarnac Dogaru\u00a0GL, Onishi\u00a0SM, Gallemore\u00a0RP (2015) Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema. Int Med Case Rep\u00a0J 8:305\u2013312. https:\/\/doi.org\/10.2147\/IMCRJ.S92794","journal-title":"Int Med Case Rep J"},{"issue":"3","key":"1122_CR33","first-page":"235","volume":"7","author":"K Ghasemi Falavarjani","year":"2012","unstructured":"Ghasemi Falavarjani\u00a0K, Parvaresh\u00a0M\u2011M, Modarres\u00a0M, Hashemi\u00a0M, Samiy\u00a0N (2012) Intravitreal bevacizumab for pseudophakic cystoid macular edema; a\u00a0systematic review. J\u00a0Ophthalmic Vis Res 7(3):235\u2013239","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"1122_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jcrs.2007.08.021","volume":"34","author":"MS Spitzer","year":"2008","unstructured":"Spitzer\u00a0MS, Ziemssen\u00a0F, Yoeruek\u00a0E, Petermeier\u00a0K, Aisenbrey\u00a0S, Szurman\u00a0P (2008) Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J\u00a0Cataract Refract Surg 34(1):70\u201375. https:\/\/doi.org\/10.1016\/j.jcrs.2007.08.021","journal-title":"J Cataract Refract Surg"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01122-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:12:37Z","timestamp":1622160757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01122-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>V.\u00a0Radeck<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Angestellte Augen\u00e4rztin, Ober\u00e4rztin, Klinik und Poliklinik Augenheilkunde, Universit\u00e4tsklinikum, Regensburg | Mitgliedschaften: DOG, BVA. <b>D.\u00a0M\u00e4rker<\/b>: Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Kostenerstattung f\u00fcr Reisen, bezahlte Teilnehmergeb\u00fchren, Referentenhonorare: Bayer, Novartis. Nichtfinanzielle Interessen: Oberarzt Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Regensburg. <b>P.\u00a0Prahs<\/b>: Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Ger\u00e4te: Fa. Nvidia. \u2013 Kostenerstattung Kongressreisen: Fa. Bayer | Referentenhonorar: Fa. Novartis. \u2013 Honorar als Schulungsreferent: Fa. Alcon. Nichtfinanzielle Interessen: Angestellter Augenarzt, Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4t Regensburg, Regensburg | Mitgliedschaft: Deutsche Ophthalmologische Gesellschaft. <b>H.\u00a0Helbig<\/b>: Finanzielle Interessen: Forschungsf\u00f6rderung von BMBF Jackst\u00e4dt-Stiftung, Velux Stiftung, Novartis Pharma, DFG f\u00fcr Forschungsvorhaben des Lehrstuhls, nicht zur freien pers\u00f6nlichen Verf\u00fcgung. \u2013 Vortragshonorare und Reisekostenerstattung: Novartis, Bayer, Allergan, Alimera. \u2013 Advisory board f\u00fcr: Allergan, Bayer, ImplantData, TheaPharma, Apellis und Novartis. Nichtfinanzielle Interessen: Direktor, Universit\u00e4tsklinikum Regensburg | Mitgliedschaften: DOG (Pressesprecher), RG Gesellschaft (Vorstand), BVA, ARVO, AAO. <b>L.\u00a0Krause<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Chefarzt, Augenklinik, St\u00e4dtisches Klinikum Dessau, Dessau.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}